RNV.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 29, 2025
Report Source: 2025 2nd Quarter Report
R
ReNerve Ltd. Stock Analysis RNV.AX
ReNerve Ltd. is a medical device company focused on the repair of peripheral nerve injuries. The firm is focused on commercializing medical devices and tissue engineering products that address significant unmet needs in peripheral nerve damage patients. The company is also developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. The company is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, tissue compatible protective wrap used to protect repaired injured nerves. The company consists of a pliable scaffolding material that can be wrapped around the nerve, protecting surgical repairs and conforming to the nerve’s final shape, allowing regeneration to occur.
Read More ReNerve Ltd (RNV.AX) Chart
Key Statistics of ReNerve Ltd (RNV.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.09Volume
27.94KP/E Ratio (TTM)
-52 Week Range
Market Cap
14.62MAvg. Volume
41.59KDividend Yield
-Financial Metrics & Statements of ReNerve Ltd (RNV.AX)
FAQ's for ReNerve Ltd (RNV.AX)
- According to Musaffa’s Shariah screening methodology, ReNerve Ltd (RNV.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.